Eventually, the market that could exceed a few hundred billion dollars, has companies throwing their R&D efforts into treating it
Pathway 1 cAMP The therapeutic signal
The FDA's shortage-based enforcement discretion periods for both semaglutide and tirzepatide compounding have ended, and the regulatory environment for compounded GLP-1 products continues to evolve
These updates aim to improve affordability and access for those paying out of pocket
Regulation of CD8 + T cell-mediated immune responses by amino acid metabolism Glutamine Glutamine is deaminated to form glutamate and -ketoglutarate (-KG), which supports anaplerosis of the TCA cycle and plays a crucial role in regulating histone methylation and chromatin accessibility (Fig
A typical transition timeline might look like this: Weeks 1-4: Start tirzepatide 2.5 mg weekly while maintaining phentermine at current dose Weeks 5-8: Increase tirzepatide to 5 mg weekly, reduce phentermine to 15 mg daily (if currently on a higher dose) Weeks 9-12: Increase tirzepatide to 7.5 mg weekly, begin tapering phentermine to every other day Week 13+: Discontinue phentermine, continue tirzepatide titration as needed This is a general framework, not a prescription
